Source: Microbial Drug Resistance. Unidade: IFSC
Subjects: RESISTÊNCIA MICROBIANA ÀS DROGAS, BIOFILMES, PEPTÍDEOS
ABNT
DABUL, Andrei Nicoli Gebieluca et al. Resistance in in vitro selected tigecycline-resistant methicillin-resistant staphylococcus aureus Sequence type 5 is driven by mutations in mepR and mepA genes. Microbial Drug Resistance, v. 24, n. 5, p. 519-526, 2018Tradução . . Disponível em: https://doi.org/10.1089/mdr.2017.0279. Acesso em: 04 jan. 2026.APA
Dabul, A. N. G., Avaca-Crusca, J. S., Tyne, D. V., Gilmore, M. S., & Camargo, I. L. B. da C. (2018). Resistance in in vitro selected tigecycline-resistant methicillin-resistant staphylococcus aureus Sequence type 5 is driven by mutations in mepR and mepA genes. Microbial Drug Resistance, 24( 5), 519-526. doi:10.1089/mdr.2017.0279NLM
Dabul ANG, Avaca-Crusca JS, Tyne DV, Gilmore MS, Camargo ILB da C. Resistance in in vitro selected tigecycline-resistant methicillin-resistant staphylococcus aureus Sequence type 5 is driven by mutations in mepR and mepA genes [Internet]. Microbial Drug Resistance. 2018 ; 24( 5): 519-526.[citado 2026 jan. 04 ] Available from: https://doi.org/10.1089/mdr.2017.0279Vancouver
Dabul ANG, Avaca-Crusca JS, Tyne DV, Gilmore MS, Camargo ILB da C. Resistance in in vitro selected tigecycline-resistant methicillin-resistant staphylococcus aureus Sequence type 5 is driven by mutations in mepR and mepA genes [Internet]. Microbial Drug Resistance. 2018 ; 24( 5): 519-526.[citado 2026 jan. 04 ] Available from: https://doi.org/10.1089/mdr.2017.0279
